Friday, March 06, 2015
 
Sign up

For Our 100% Free Stock Alerts!

 


http://finance.crwe-pr.com/wp-content/uploads/2015/02/crwe_finance.jpg





http://crwepressrelease.com/wp-content/uploads/2014/06/free_pr.jpg




http://finance.crwe-pr.com/wp-content/uploads/2014/06/add_newsletter.jpg



Follow Us On
facebookFacebook
 
 

Nanosphere (NSPH) FDA Green Light for Enteric Pathogens Nucleic Acid Test, Miller Energy Resources (MILL) Aggressive Targeted Reduction

 

http://finance.crwe-pr.com/wp-content/uploads/2014/06/nsph.jpg Nanosphere, Inc. (NSPH)

Diarrhea, which is characterized by frequent and watery bowel movements, is often caused by gastrointestinal infections, although it can also come from other illnesses or changes in diet. Germs such as parasites, viruses, or bacteria all can cause gastrointestinal infections.

Diarrhea caused by bacterial and viral infection represents a significant healthcare burden in the U.S. While most cases of community-acquired diarrhea are self-resolving and not life-threatening, gastrointestinal infections in the U.S. are associated with 3.7 million emergency department visits, 1.3 million inpatient hospitalizations and more than $6 billion in healthcare costs per year.

Since symptoms alone are insufficient to make treatment decisions, rapid identification of the bacterial or viral cause of diarrhea is critical for optimal patient management, limiting the prescription of inappropriate or unnecessary antibiotics.

NSPH reported that it has received U.S. FDA 510(k) clearance for the bacterial portion of its Verigene(R) Enteric Pathogens Nucleic Acid Test (EP). Clinical studies for the full panel, including two additional viral targets, have been completed and NSPH expects clearance of the full EP panel.

NSPH‘s Verigene EP is an automated in vitro diagnostic test that simultaneously identifies a broad panel of common community-acquired pathogenic enteric bacteria and genetic virulence markers directly from a stool sample, two to three days faster than the time- and labor-intensive conventional identification methods.

http://finance.crwe-pr.com/wp-content/uploads/2014/06/nsphch.png

NSPH is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics.

More about Nanosphere, Inc. (NSPH) at www.nanosphere.us.

**

http://finance.crwe-pr.com/wp-content/uploads/2014/06/mill.jpg Miller Energy Resources, Inc. (MILL)

MILL reported plans to divest its Tennessee assets, and has engaged in strategic discussions to that end. In addition, MILL has commenced implementation of an internal restructuring and cost reduction program designed to reduce annual general and administrative expenses by $3 to $5 million.

According to MILL, its capital is clearly better allocated to the company’s Alaskan operations and the investment opportunities that exist there.

MILL is committed to increasing EBITDA through increased production and reduced costs, and positioning MILL as a uniquely attractive pure play exploration and production company.

http://finance.crwe-pr.com/wp-content/uploads/2014/06/millch.png

MILL is an oil and natural gas exploration, production and drilling company operating in multiple exploration and production basins in North America.

More about Miller Energy Resources, Inc. (MILL) at www.millerenergyresources.com

**

Read Full Disclaimer at www.finance.crwe-pr.com/disclaimer

Read our full Disclaimer
 
Share/Bookmark
 

 
  • CRWE Network

http://finance.crwe-pr.com/wp-content/uploads/2014/11/wsa2.jpg



Augury Sentiment For Friday


http://finance.crwe-pr.com/wp-content/uploads/2015/03/cala2.jpg



http://finance.crwe-pr.com/wp-content/uploads/2015/01/crwejan16.jpg